Amyloid proteins, which are considered 'villains' in many neurodegenerative diseases, form
enigmatic pathological strains that underlie disease pathogenesis and progression. Recent …

The synucleinopathies—Parkinson's disease, dementia with Lewy bodies, multiple system
atrophy, and pure autonomic failure—result from distinct patterns of abnormal α‐synuclein …

The α-synucleinopathies are a group of neurodegenerative diseases characterized by
abnormal accumulation of insoluble α-synuclein in neurons and glial cells, comprising …

Objective: To develop a cutaneous biomarker for Parkinson disease (PD). Methods: Twenty
patients with PD and 14 age-and sex-matched control subjects underwent examinations …

The search for markers of preclinical Parkinson disease (PD) is becoming increasingly
important because pathogenesis-targeted neuroprotective strategies are being developed …

Lewy body disease (LBD) is a spectrum of progressive neurodegenerative disorders
characterized by the wide distribution of Lewy bodies and neurites in the central and …

Dysphagia is very common in patients with Parkinson disease (PD) and often leads to
aspiration pneumonia, the most common cause of death in PD. Current therapies are largely …

Parkinson's disease is the second most frequent neurodegenerative disorder. While most
cases occur sporadic mutations in a growing number of genes including Parkin (PARK2) …

Dysphagia (impaired swallowing) is common in patients with Parkinson disease (PD) and is
related to aspiration pneumonia, the primary cause of death in PD. Therapies that …

Parkinson disease (PD) is a neurodegenerative disease primarily characterized by cardinal
motor manifestations and CNS pathology. Current drug therapies can often stabilize these …